Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 12:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 1,131 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Functional MRI Clear all

Conditions: Smoking
Interventions: Smoking Abstinence; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Menopause
Interventions: Choline, Placebo; Dietary Supplement
Lead sponsor: Julie Dumas; Other
Eligibility: 50 Years to 65 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: ALS, Amyotrophic Lateral Sclerosis
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Addiction Nicotine
Interventions: Neurofeedback (from fMRI and/or EEG); Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Traumatic Brain Injury, Closed Head Injury, Cognitive Dysfunction
Interventions: Real LED Intervention, Sham LED Intervention; Device
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alcohol Drinking, Alcohol Use Disorder
Interventions: Ketone Ester "(R)-3-hydroxybutyl (R)-3-hydroxybutyrate", Isocaloric dextrose placebo, Alcohol drinks; Dietary Supplement · Drug · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bulimia Nervosa, Binge-Eating Disorder, Obesity, Eating Disorder
Interventions: Negative Affect Task; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 55 Years
Enrollment: 410 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Contrast Enhancement in Magnetic Resonance Imaging
Interventions: BAY1747846; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Miami, Florida • Knoxville, Tennessee

Conditions: Marijuana, THC, Cannabis
Interventions: Marijuana, Hash, THC, or Grass, Placebo; Drug
Lead sponsor: Hartford Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Human Development
Interventions: MRI; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 30 Weeks to 45 Weeks
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Movement Disorders
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 8 Years and older
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cerebral Amyloid Angiopathy
Interventions: Ponezumab, placebo; Biological · Other
Lead sponsor: Pfizer; Industry
Eligibility: 55 Years to 90 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 7
States / cities: Los Angeles, California • Boston, Massachusetts • Charlestown, Massachusetts + 2 more

Conditions: Anxiety, Social Anxiety Disorder, Panic Disorder, Generalized Anxiety Disorder
Interventions: Functional magnetic resonance imaging (fMRI) with Veritable-NF, fMRI with Sham-NF; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 24 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Tobacco Use Disorder
Interventions: Clavulanic Acid, Placebo oral capsule; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Social Cognition, Personality Disorder, Mental Health, Interpersonal Conflict
Interventions: Social Learning Task Battery, Clinical Cohort, Social Learning Task Battery, Online Cohort; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1,612 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Stroke, Broca's Aphasia
Interventions: Cortical Electrical Stimulation; Device
Lead sponsor: Northstar Neuroscience; Industry
Eligibility: 21 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Tobacco Use Disorder
Interventions: low intensity focused ultrasound (LIFU); Device
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Major Depressive Disorder, Substance Use Disorder, Normal Physiology
Interventions: Placebo Nicotine Patch, Nicotine Patch; Other · Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 620 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Obsessive-Compulsive Disorder, Tic Disorders, Tourette Syndrome
Interventions: Ondansetron, Placebo; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 60 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: New York, New York

Conditions: HIV Infection
Interventions: Adaptive WM CogMed Training, Nonadaptive WM CogMed Training; Other
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years to 85 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pulmonary Surgical Procedures
Interventions: 129Xe MRI, 133XE scintigraphy; Drug
Lead sponsor: Polarean, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Durham, North Carolina • Charlottesville, Virginia

Conditions: Bipolar Disorder I or II, Healthy (Controls)
Interventions: Think and Regulate Affective State Task; Behavioral
Lead sponsor: Laureate Institute for Brain Research, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Schizophrenia
Interventions: Electroencephalography (EEG) and Magnetic Resonance Imaging (MRI); Diagnostic Test
Lead sponsor: San Francisco Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity, Gliosis, Weight-Loss
Interventions: Behavioral Weight Loss Program, Roux-en-Y Gastric Bypass or Sleeve Gastrectomy; Behavioral · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 25 Years to 64 Years
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Search by objective public record fields.

Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence

Choline Dose Ranging in Postmenopausal Women

Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)

Self-activation in Individuals With and Without Nicotine Dependence

Photobiomodulation to Improve Cognition in TBI, With fMRI

Ketone Ester Intervention in Alcohol Use Disorder

Effects of Negative Affect in Individuals With Binge Eating Episodes

A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function

THC Memory & Reward Learning Pilot

Characterization of the Functional and Structural Development of the Human Neonatal Brain From 30 Wks to 45 Wks ga

Neurophysiological Studies in Patients With Paroxysmal Hyperkinetic Movement Disorders

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4

An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Neurocomputational Dynamics of Cooperation

Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia.

Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula

Defining Neurobiological Links Between Substance Use and Mental Illness

Effects of Ondansetron in Obsessive-compulsive and Tic Disorders

Neural Correlates of Working Memory Training for HIV Patients

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Transplant

Decoding Emotional Dynamics in Bipolar Disorder

Brain Imaging, Attention, and Auditory Processing in Schizophrenia

A Cohort Study of Weight Loss and Gliosis